Biocon Limited (BOM:532523)
India · Delayed Price · Currency is INR 372.65
+8.10 (2.22%)
At close: Jan 22, 2026
Biocon Revenue
Biocon had revenue of 42.96B INR in the quarter ending September 30, 2025, with 19.64% growth. This brings the company's revenue in the last twelve months to 164.76B, up 10.62% year-over-year. In the fiscal year ending March 31, 2025, Biocon had annual revenue of 152.62B with 3.43% growth.
Revenue (ttm)
164.76B
Revenue Growth
+10.62%
P/S Ratio
3.66
Revenue / Employee
10.03M
Employees
16,315
Market Cap
603.65B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
| Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarti Drugs | 24.77B |
| Hester Biosciences | 3.11B |
| Titan Biotech | 1.74B |
| Zenotech Laboratories | 403.29M |
| Bharat Immunologicals & Biologicals Corporation | 76.50M |
| Genesis IBRC India | 36.67M |
| Hindustan Bio Sciences | 7.32M |
| Transgene Biotek | 2.55M |
Biocon News
- 11 days ago - Pharma sector stocks down today: Divi’s Laboratories falls nearly 3%, Biocon drops 1.09%, Sun Pharma down 0.45% - Business Upturn
- 16 days ago - Top stocks to watch today, January 7: Titan Company, Mahindra, Godrej Consumer, Jubilant, Biocon and more - Business Upturn
- 23 days ago - Biocon employee found dead on Bengaluru campus, police probe underway - Business Upturn
- 23 days ago - Biocon staffer jumps to death from office building in Bengaluru - The Times of India
- 23 days ago - Biocon Employee, 26, Found Dead At Bengaluru Office - NDTV
- 4 weeks ago - Ajanta Pharma shares jump over 4% after signing in-licensing agreement with Biocon - Business Upturn
- 4 weeks ago - Biocon signs out-licensing deal with Ajanta Pharma to market Semaglutide in overseas markets - Business Upturn
- 4 weeks ago - Biocon Biologics secures full global rights for Hulio biosimilar Adalimumab - Business Upturn